Santero Therapeutics
The computed 12-month bankruptcy probability of Santero Therapeutics is 1.9% (moderate). The 2024 annual accounts show equity of €2.53M and a net result of €-2.30M. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 92% of 43 sector peers (fiscal year 2024). The company has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €2.53M |
| Net result | €-2.30M |
| Staff (FTE) | 8.4 |
| Better than sector | 92% |
Strong profile, led by solvency.
All 5 axes are computed from data Checked has read.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
The full score breakdown, per-year score history and the indicative credit limit are in Kantoor S.
See plans →How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 84.3% | 53.3% | |
| Net result | €-2.30M | €-19k | |
| Equity | €2.53M | €685k | |
| Gross operating margin | €470k | €7k | |
| Staff costs | €733k | €723k |
Show 11 other metrics
| Fiscal year | 2024 |
|---|---|
| Deposit | volledig |
| Revenue | - |
| EBITDA | €-275k |
| Net profit | €-2.30M |
| Cash flow | €-68k |
| Staff costs | €733k |
| Income taxes | €-160k |
| Dividends | - |
| Total assets | €3.00M |
| Equity | €2.53M |
| Debt | €472k |
| of which ≤ 1y | €472k |
| of which > 1y | €0 |
| Working capital | €2.20M |
| Employees (FTE) | 8.4 |
| 2024 | |
|---|---|
| Current ratio | 5.67 |
| Quick ratio | 5.67 |
| Working capital ratio | 73.5% |
| Solvency | 84.3% |
| Debt / equity | 0.19 |
| Long-term debt ratio | 0.00 |
| Interest coverage | -15.31 |
| Gross margin | - |
| Net margin | - |
| ROA | -76.7% |
| ROE | -91.0% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
Full annual accounts (23 line items)
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €3.00M |
| Fixed assets | 21/28 | €323k |
| Tangible fixed assets | 22/27 | €323k |
| Financial fixed assets | 28 | €100 |
| Current assets | 29/58 | €2.68M |
| Amounts receivable within one year | 40/41 | €456k |
| Cash & bank | 54/58 | €2.14M |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €3.00M |
| Equity | 10/15 | €2.53M |
| Contributions / capital | 10/11 | €6.31M |
| Accumulated profits (losses) | 14 | €-3.78M |
| Amounts payable | 17/49 | €472k |
| Amounts payable after one year | 17 | €0 |
| Amounts payable within one year | 42/48 | €472k |
| Trade debts payable within one year | 44 | €279k |
| Income statement | ||
| Gross operating margin | 9900 | €470k |
| Operating result | 9901 | €-2.51M |
| Financial income | 75 | €65k |
| Financial charges | 65 | €18k |
| Result before taxes | 9903 | €-2.46M |
| Income taxes | 67/77 | €-160k |
| Net result for the period | 9904 | €-2.30M |
| Result to be appropriated | 9905 | €-2.30M |
-
NEWTON BIOCAPTAL IILegal entityDirector· perm. rep.: Tomoko ASAOKAState Gazette act 26003640 (08-01-2026)Current18-01-2025 → present
-
Current24-10-2024 → present
-
Current24-10-2024 → present
-
NEWTON BIOCAPITALLegal entityDirector· perm. rep.: Jean COMBALBERTState Gazette act 25057329 (05-05-2025)Current16-10-2024 → present
-
Current20-12-2021 → present
2 events
- 26-05-2023 Appointed· Daily management
- 20-12-2021 Appointed· Director
-
Current29-08-2021 → present
Show 2 more sitting directors
-
MichelConsultLegal entityDirector· perm. rep.: Michel GOLDMANState Gazette act 21126187 (22-10-2021)Current29-08-2021 → present
-
Current29-08-2021 → present
Former directors (2)
-
Former- → 28-07-2021
-
Former- → 28-07-2021
| Statutory auditor | IRE/IBR number | Tenure |
|---|---|---|
| SRL Deloitte Réviseurs d'entrepriseCurrent Statutory auditor · represented by Julie Delforge |
- | 24-10-2024 → present |
| NACE primary | Speur- en ontwikkelingswerk op biotechnologisch gebied(72101) |
| Legal form | Private limited company(610) |
| Incorporation | 29-03-2021 |
| Status | Active |
| Postal code | 6041 |
Show 2 more network connections
Each band states what its claims rest on. A board seat is influence over the board, not ownership. Court mandates (receiver, interim administrator) and liquidation mandates do not link companies and are therefore absent here; they belong under Directors & mandates.
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 25020B0074/00B002 | Wallonia | 6.2 ha | 1 · 17 m² | 7.8 m · 2 fl. |
| 21445C0281/00V006 | Brussels | 1.2 ha | - | - |
| 52028B0295/02C000 | Wallonia | 7,830 m² | - | - |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
We know of 13 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
27-02-2026 Mark BEARDS appointed as daily management delegate
- Mark BEARDS, Dagelijks bestuur
Technical details
{
"events": [
{
"kind": "decharge_granted",
"role": "d\u00E9l\u00E9gu\u00E9 \u00E0 la gestion journali\u00E8re",
"person": {
"rrn": null,
"name": "Abel GARCIA-PINO",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": "2025-12-18",
"evidence_quote": "prend acte et approuve la d\u00E9mission de Monsieur Abel GARCIA-PINO de ses fonctions de d\u00E9l\u00E9gu\u00E9 \u00E0 la gestion journali\u00E8re, avec effet au 18 d\u00E9cembre 2025.",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "delegation_dagelijks_bestuur_in",
"role": "d\u00E9l\u00E9gu\u00E9 \u00E0 la gestion journali\u00E8re",
"person": {
"rrn": null,
"name": "Mark BEARDS",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": {
"kbo": null,
"name": "FOUNTAINHEAD CONSULTING LIMITED",
"address": "The Carriage House, Mill Street, Maidstone, Kent, UK ME15 6YE",
"country": "GB",
"legal_form": "SRL"
},
"statutory": null,
"compensated": null,
"effective_date": "2025-12-18",
"evidence_quote": "nomme FOUNTAINHEAD CONSULTING LIMITED, soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e constitu\u00E9e Angleterre et au Pays de Galles, ayant son si\u00E8ge \u00E0 The Carriage House, Mill Street, Maidstone, Kent, UK ME15 6YE, immatricul\u00E9e sous le num\u00E9ro 11080386 et sous le num\u00E9ro de TVA 287360083, repr\u00E9sent\u00E9e par son repr\u00E9senta",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "substantive_delegation",
"role": "avocat",
"person": null,
"reason": null,
"subkind": null,
"via_org": {
"kbo": null,
"name": "Fieldfisher (Belgium) LLP",
"address": "1040 Bruxelles, Boulevard Louis Schmidt 29/15",
"country": "BE",
"legal_form": null
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "Le conseil d\u0027administration d\u00E9cide de donner procuration \u00E0 tout avocat du cabinet Fieldfisher (Belgium) LLP situ\u00E9 \u00E0 1040 Bruxelles, Boulevard Louis Schmidt 29/15",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "substantive_delegation",
"role": "avocat",
"person": {
"rrn": null,
"name": "David RICHELLE",
"address": null,
"birth_date": null,
"profession": "avocat",
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": {
"kbo": null,
"name": "Corpoconsult SRL",
"address": "1050 Bruxelles, Avenue Louise 200, boite 21",
"country": "BE",
"legal_form": "SRL"
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "ainsi qu\u0027\u00E0 Corpoconsult SRL, dont le si\u00E8ge est \u00E9tabli \u00E0 1050 Bruxelles, Avenue Louise 200, boite 21 repr\u00E9sent\u00E9e par Monsieur David RICHELLE",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "publication_proxy",
"role": null,
"person": {
"rrn": null,
"name": "David Richelle",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": {
"kbo": null,
"name": "Corpoconsult Srl",
"address": null,
"country": null,
"legal_form": null
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "Mandataire sp\u00E9cial",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "mixed",
"pub_date": "2026-02-27",
"filing_date": "2025-12-18",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decisions": [
{
"body": "conseil_d\u0027administration",
"date": "2025-12-18",
"unanimous": null
}
],
"is_correction": false,
"subject_company": {
"kbo": "0765.790.155",
"name_full": "SANTERO THERAPEUTICS",
"legal_form": "SRL"
},
"publication_proxy": {
"kind": "org",
"org_kbo": null,
"org_name": "Corpoconsult Srl",
"person_name": null,
"org_rep_person_name": "David Richelle",
"person_role_at_subject": null
},
"co_filed_documents": [],
"corrected_publication_numac": null
}08-01-2026 Tomoko ASAOKA reappointed as director
- Tomoko ASAOKA, Bestuurder
Technical details
{
"events": [
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Tomoko ASAOKA",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "NEWTON BIOCAPTAL II",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2025-01-18",
"evidence_quote": "Les Administrateurs prennent acte de la d\u00E9signation de Madame Tomoko ASAOKA en qualit\u00E9 de repr\u00E9sentant permanent de NEWTON BIOCAPTAL II, administrateur personne morale de la Soci\u00E9t\u00E9, en remplacement de Monsieur Jean COMBALBERT"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0765.790.155",
"name_full": "SANTERO THERAPEUTICS",
"legal_form": "SRL"
}
}05-05-2025 Jean COMBALBERT appointed as director
- Jean COMBALBERT, Bestuurder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Jean COMBALBERT",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "NEWTON BIOCAPITAL",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2024-10-16",
"evidence_quote": "et d\u00E9cide de nommer pour le remplacer, la soci\u00E9t\u00E9 anonyme, NEWTON BIOCAPITAL repr\u00E9sent\u00E9e par Monsieur Jean COMBALBERT, en tant que repr\u00E9sentant permanent avec effet au 16 octobre 2024."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0765.790.155",
"name_full": "SANTERO THERAPEUTICS",
"legal_form": "SRL"
}
}13-03-2025 Articles of association amended
Technical details
{
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"statute_change": {
"name_change": false,
"seat_change": false,
"object_change": false,
"effective_date": "2025-03-03",
"legal_form_change": false
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0765.790.155",
"name_full": "SANTERO THERAPEUTICS",
"legal_form": "SRL"
},
"signature_regime": null,
"special_mandates": [],
"governance_change": {
"admin_delegated_added": []
}
}12-02-2025 Registered office moved within Charleroi
- Rue Auguste Piccard 48, 6041 Charleroi → Rue Clément Ader 10, 6041 Charleroi
Technical details
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "statutaire",
"new_address": {
"city": "Charleroi",
"region": null,
"street": "Rue Cl\u00E9ment Ader",
"country": "BE",
"postcode": "6041",
"box_number": null,
"street_number": "10"
},
"old_address": {
"city": "Charleroi",
"region": null,
"street": "Rue Auguste Piccard",
"country": "BE",
"postcode": "6041",
"box_number": null,
"street_number": "48"
},
"effective_date": "2024-06-01",
"evidence_quote": "d\u00E9cident de transf\u00E9rer le si\u00E8ge de la Soci\u00E9t\u00E9 anciennement situ\u00E9 Rue Auguste Piccard 48, 6041 Charleroi, \u00E0 l\u0027adresse suivante: Rue Cl\u00E9ment Ader 10, 6041 Charleroi avec effet au 1er juin 2024."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0765.790.155",
"name_full": "SANTERO THERAPEUTICS",
"legal_form": "SRL"
}
}24-10-2024 3 directors appointed
- Julie Delforge, Commissaris
- Gökhan Batur, Bestuurder
- Albert Palomer Benet, Bestuurder
Technical details
{
"events": [
{
"kind": "commissaris_in",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Julie Delforge",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "Deloitte R\u00E9viseurs d\u0027Entreprise SRL",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale d\u00E9cide \u00E0 l\u0027unanimit\u00E9 de nommer comme r\u00E9viseur Deloitte R\u00E9viseurs d\u0027Entreprise SRL, dont le si\u00E8ge social est situ\u00E9 Gateway Building, Luchthaven Brussel Nationnaal 1J, 1930 Zaventem, repr\u00E9sent\u00E9e par Julie Delforge pour une dur\u00E9e de 3 ans, venant \u00E0 expiration imm\u00E9diatement apr\u00E8s l\u0027"
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "G\u00F6khan Batur",
"address": null,
"birth_date": null
},
"evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale d\u00E9cide \u00E0 l\u0027unanimit\u00E9 de nommer en qualit\u00E9 d\u0027administrateur les personnes suivantes pour une dur\u00E9e de 5 ans, venant \u00E0 expiration imm\u00E9diatement apr\u00E8s l\u0027assembl\u00E9e g\u00E9n\u00E9rale annuelle de l\u0027an 2029: - Monsieur G\u00F6khan Batur"
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Albert Palomer Benet",
"address": null,
"birth_date": null
},
"evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale d\u00E9cide \u00E0 l\u0027unanimit\u00E9 de nommer en qualit\u00E9 d\u0027administrateur les personnes suivantes pour une dur\u00E9e de 5 ans, venant \u00E0 expiration imm\u00E9diatement apr\u00E8s l\u0027assembl\u00E9e g\u00E9n\u00E9rale annuelle de l\u0027an 2029: - Monsieur Albert Palomer Benet"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0765.790.155",
"name_full": "SANTERO THERAPEUTICS",
"legal_form": "SRL"
}
}31-01-2024 Capital increase of €4,075,000
- 3 kapitaalbewegingen in deze akte
Technical details
{
"events": [
{
"kind": "capital_increase",
"amount": 4075000.0,
"currency": "EUR",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"amount_type": "kapitaal_toegestaan",
"effective_date": "2024-01-16",
"evidence_quote": "I. La p\u00E9riode de souscription relative \u00E0 l\u2019apport suppl\u00E9mentaire en num\u00E9raire \u00E0 concurrence d\u2019un montant maximum de 4.075.000,00 EUR",
"contribution_type": "cash"
},
{
"kind": "capital_increase",
"amount": 4050000.0,
"currency": "EUR",
"after_eur": null,
"delta_eur": 4050000.0,
"before_eur": null,
"amount_type": "kapitaal_effectief",
"effective_date": "2024-01-16",
"evidence_quote": "IV. Le prix de souscription a \u00E9t\u00E9 fix\u00E9 au prix de 10,00 EUR par nouvelle action et chacune des actions ainsi souscrites a \u00E9t\u00E9 lib\u00E9r\u00E9e \u00E0 concurrence d\u2019un montant total de 4.050.000,00 EUR.",
"contribution_type": "cash"
},
{
"kind": "capital_increase",
"amount": 4075000.0,
"currency": "EUR",
"after_eur": null,
"delta_eur": 4075000.0,
"before_eur": null,
"amount_type": "kapitaal_effectief",
"effective_date": "2024-01-16",
"evidence_quote": "VI. Il r\u00E9sulte de ce qui pr\u00E9c\u00E8de que le compte de capitaux propres est effectivement augment\u00E9 \u00E0 concurrence d\u2019un montant total de 4.075.000,00 EUR",
"contribution_type": "cash"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0765.790.155",
"name_full": "SANTERO THERAPEUTICS",
"legal_form": "SRL"
}
}08-01-2024 Abel Garcia Pino appointed as daily management
- Abel Garcia Pino, Dagelijks bestuur
Technical details
{
"events": [
{
"kind": "director_in",
"role": "dagelijks_bestuur",
"person": {
"rrn": null,
"name": "Abel Garcia Pino",
"address": null,
"birth_date": null
},
"effective_date": "2023-05-26",
"evidence_quote": "Le conseil d\u0027administration approuve la nomination de Monsieur Abel Garcia Pino, domicili\u00E9 \u00E0 1150 Bruxelles, Clos des Chats 25A, en qualit\u00E9 de d\u00E9l\u00E9gu\u00E9 \u00E0 la gestion journali\u00E8re et, pour autant que de besoin, ratifie les actes qui auraient \u00E9t\u00E9 pos\u00E9s en cette qualit\u00E9 par Monsieur Abel Garcia Pino en ce"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0765.790.155",
"name_full": "SANTERO THERAPEUTICS",
"legal_form": "SRL"
}
}02-06-2023 Change in the board of directors
Technical details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0765.790.155",
"name_full": "SANTERO THERAPEUTICS",
"legal_form": "SRL"
}
}07-01-2022 Abel GARCIA PINO appointed as director
- Abel GARCIA PINO, Bestuurder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Abel GARCIA PINO",
"address": null,
"birth_date": null
},
"effective_date": "2021-12-20",
"evidence_quote": "Le conseil d\u0027administration d\u00E9cide de nommer Monsieur Abel GARCIA PINO, domicili\u00E9 \u00E0 1150 Woluwe-Saint-Pierre, Clos des Chats 25 A, qui accepte, comme (second) administrateur d\u00E9l\u00E9gu\u00E9 pour une dur\u00E9e ind\u00E9termin\u00E9e et ce avec effet imm\u00E9diat."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0765.790.155",
"name_full": "SANTERO THERAPEUTICS",
"legal_form": "SRL"
}
}22-10-2021 3 directors appointed, 2 resigning
- Albert KESSLER, Bestuurder
- Pierre DRION, Bestuurder
- Michel GOLDMAN, Bestuurder
- Daniele CARATI, Bestuurder
- Didier GEORGES, Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Daniele CARATI",
"address": null,
"birth_date": null
},
"effective_date": "2021-07-28",
"evidence_quote": "a) prennent acte de la d\u00E9mission des administrateurs suivants avec effet au 28 juillet 2021 [...] M. Daniele CARATI"
},
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Didier GEORGES",
"address": null,
"birth_date": null
},
"effective_date": "2021-07-28",
"evidence_quote": "a) prennent acte de la d\u00E9mission des administrateurs suivants avec effet au 28 juillet 2021 [...] M. Didier GEORGES"
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Albert KESSLER",
"address": null,
"birth_date": null
},
"effective_date": "2021-08-29",
"evidence_quote": "b) d\u00E9cident de nommer en tant qu\u0027administrateurs, et ce avec effet imm\u00E9diat: M. Albert KESSLER"
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Pierre DRION",
"address": null,
"birth_date": null
},
"effective_date": "2021-08-29",
"evidence_quote": "b) d\u00E9cident de nommer en tant qu\u0027administrateurs, et ce avec effet imm\u00E9diat: M. Pierre DRION"
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Michel GOLDMAN",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": "0657984850",
"name": "MICHELCONSULT SRL",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2021-08-29",
"evidence_quote": "b) d\u00E9cident de nommer en tant qu\u0027administrateurs, et ce avec effet imm\u00E9diat: MICHELCONSULT SRL [...] repr\u00E9sent\u00E9e par son repr\u00E9sentant permanent M. Michel GOLDMAN"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0765.790.155",
"name_full": "SANTERO THERAPEUTICS",
"legal_form": "SRL"
}
}12-08-2021 Articles of association amended
Technical details
{
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"statute_change": {
"name_change": false,
"seat_change": false,
"object_change": false,
"effective_date": "2021-07-28",
"legal_form_change": false
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0765.790.155",
"name_full": "SANTERO THERAPEUTICS",
"legal_form": "SRL"
},
"signature_regime": null,
"special_mandates": [
{
"quote": "au notaire soussign\u00E9 pour d\u00E9poser la coordination des statuts au Greffe du Tribunal de l\u2019Entreprise ; - au notaire soussign\u00E9 pour d\u00E9poser une copie du pr\u00E9sent acte au greffe du tribunal de l\u2019Entreprise pour publication dans les Annexes du Moniteur Belge",
"holder_kbo": null,
"holder_name": "Sophie MAQUET",
"scope_categories": [
"filing",
"publication"
],
"with_substitution": false
},
{
"quote": "\u00E0 l\u2019organe d\u2019administration, \u00E0 tout autre avocat du cabinet Fieldfisher (Belgium) LLP, qui tous, \u00E0 cet effet, \u00E9lisent domicile dans les bureaux du cabinet Fieldfisher (Belgium) LLP, situ\u00E9s \u00E0 1040 Bruxelles, boulevard Louis Schmidt 29",
"holder_kbo": null,
"holder_name": "Fieldfisher (Belgium) LLP",
"scope_categories": [
"filing",
"tax",
"kbo"
],
"with_substitution": false
},
{
"quote": "\u00E0 Corpoconsult SRL, dont le si\u00E8ge est \u00E9tabli \u00E0 1060 Bruxelles, rue Fernand Bernier 15, repr\u00E9sent\u00E9e par David Richelle, avec pouvoir de subd\u00E9l\u00E9gation, pour accomplir les formalit\u00E9s n\u00E9cessaires en vue de modifier l\u0027inscription de la soci\u00E9t\u00E9 aupr\u00E8s de toutes Administrations comp\u00E9tentes.",
"holder_kbo": null,
"holder_name": "Corpoconsult SRL",
"scope_categories": [
"filing",
"tax",
"kbo"
],
"with_substitution": true
}
],
"governance_change": {
"admin_delegated_added": []
}
}31-03-2021 Incorporation of a new SRL
Technical details
{
"kind": "oprichting",
"seat": "Rue Auguste Piccard 48, 6041 Gosselies",
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"founders": [
{
"org": null,
"kind": "natural_person",
"person": {
"dob": "1978-04-19",
"name": "GARCIA PINO Abel",
"niss": null,
"address": "1150 Woluwe-Saint-Pierre, Clos des Chats 25 A"
},
"share_class": "Ordinary",
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": null,
"contribution_type": "cash",
"amount_paid_in_eur": 1000,
"holder_person_name": "GARCIA PINO Abel",
"is_subscriber_only": false,
"n_shares_subscribed": 100,
"amount_subscribed_eur": 1000,
"is_anonymous_silent_partner": false
},
{
"org": null,
"kind": "natural_person",
"person": {
"dob": "1973-11-04",
"name": "GOVAERTS C\u00E9dric Pierre Michel",
"niss": null,
"address": "1180 Uccle, Dr\u00E8ve des Gendarmes 159"
},
"share_class": "Ordinary",
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": null,
"contribution_type": "cash",
"amount_paid_in_eur": 1000,
"holder_person_name": "GOVAERTS C\u00E9dric Pierre Michel",
"is_subscriber_only": false,
"n_shares_subscribed": 100,
"amount_subscribed_eur": 1000,
"is_anonymous_silent_partner": false
},
{
"org": {
"kbo": "0859.775.138",
"name": "ULB DEV\u0027"
},
"kind": "rechtspersoon",
"person": null,
"share_class": "Ordinary",
"partner_role": null,
"holder_org_kbo": "0859.775.138",
"holder_org_name": "ULB DEV\u0027",
"contribution_type": "cash",
"amount_paid_in_eur": 8000,
"holder_person_name": null,
"is_subscriber_only": false,
"n_shares_subscribed": 800,
"amount_subscribed_eur": 8000,
"is_anonymous_silent_partner": false
}
],
"capital_eur": 10000,
"subject_company": {
"kbo": "0765.790.155",
"name_full": "Santero Therapeutics",
"legal_form": "SRL"
},
"initial_directors": [],
"incorporation_date": "2021-03-25",
"post_incorporation_mandates": []
}| Legal nameFR | Santero Therapeutics |